170 related articles for article (PubMed ID: 11462292)
1. SonoVue in transcranial Doppler investigations of the cerebral arteries.
Kaps M; Legemate DA; Ries F; Ackerstaff RG; Markus H; Pezzoll C; Llull JB; Spinazzi A
J Neuroimaging; 2001 Jul; 11(3):261-7. PubMed ID: 11462292
[TBL] [Abstract][Full Text] [Related]
2. A new Doppler signal enhancing agent for flow assessment in breast lesions.
Madjar H; Prömpeler HJ; Del Favero C; Hackelöer BJ; Llull JB
Eur J Ultrasound; 2000 Dec; 12(2):123-30. PubMed ID: 11118919
[TBL] [Abstract][Full Text] [Related]
3. Transcranial duplex imaging with a sulfurhexafluoride echocontrast agent: enhancement and diagnostic quality.
Schweikert K; Operschall C; Llull JB; Lyrer P
J Neuroimaging; 2002 Jan; 12(1):19-27. PubMed ID: 11826593
[TBL] [Abstract][Full Text] [Related]
4. Safety and ultrasound-enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation.
Kaps M; Seidel G; Bokor D; Modrau B; Algermissen C
J Neuroimaging; 1999 Jul; 9(3):150-4. PubMed ID: 10436756
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study.
Sidhu PS; Allan PL; Cattin F; Cosgrove DO; Davies AH; Do DD; Karakagil S; Langholz J; Legemate DA; Martegani A; Llull JB; Pezzoli C; Spinazzi A
Br J Radiol; 2006 Jan; 79(937):44-51. PubMed ID: 16421404
[TBL] [Abstract][Full Text] [Related]
6. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions.
Leen E; Angerson WJ; Yarmenitis S; Bongartz G; Blomley M; Del Maschio A; Summaria V; Maresca G; Pezzoli C; Llull JB
Eur J Radiol; 2002 Mar; 41(3):200-6. PubMed ID: 11861094
[TBL] [Abstract][Full Text] [Related]
7. SonoVue (BR1), a new long-acting echocontrast agent, improves transcranial colour-coded duplex ultrasonic imaging.
Droste DW; Llull JB; Pezzoli C; Bogdahn U; Kaps M
Cerebrovasc Dis; 2002; 14(1):27-32. PubMed ID: 12097848
[TBL] [Abstract][Full Text] [Related]
8. Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent: A European multicenter study.
Senior R; Andersson O; Caidahl K; Carlens P; Herregods MC; Jenni R; Kenny A; Melcher A; Svedenhag J; Vanoverschelde JL; Wandt B; Widgren BR; Williams G; Guerret P; la Rosee K; Agati L; Bezante G
Echocardiography; 2000 Nov; 17(8):705-11. PubMed ID: 11153016
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Enhanced Transcranial and Extracranial Duplex Sonography: Preliminary Results of a Multicenter Phase II/III Study with SonoVuetrade mark.
Bogdahn U; Hölscher T; Rosin L; Götz B; Schlachetzki F
Echocardiography; 1999 Oct; 16(7, Pt 2):761-766. PubMed ID: 11175220
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of echocontrast agent infusion in a dog model.
Kaps M; Seidel G; Algermissen C; Gerriets T; Broillet A
J Neuroimaging; 2001 Jul; 11(3):298-302. PubMed ID: 11462298
[TBL] [Abstract][Full Text] [Related]
11. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging.
Morel DR; Schwieger I; Hohn L; Terrettaz J; Llull JB; Cornioley YA; Schneider M
Invest Radiol; 2000 Jan; 35(1):80-5. PubMed ID: 10639039
[TBL] [Abstract][Full Text] [Related]
12. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease.
Bokor D; Chambers JB; Rees PJ; Mant TG; Luzzani F; Spinazzi A
Invest Radiol; 2001 Feb; 36(2):104-9. PubMed ID: 11224758
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic efficacy of SonoVue.
Bokor D
Am J Cardiol; 2000 Aug; 86(4A):19G-24G. PubMed ID: 10997347
[TBL] [Abstract][Full Text] [Related]
14. Ovine model to evaluate ovarian vascularization by using contrast-enhanced sonography.
Marret H; Brewer M; Giraudeau B; Tranquart F; Voelker K; Satterfield W
Comp Med; 2005 Apr; 55(2):150-5. PubMed ID: 15884777
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of SonoVue for improved endocardial border delineation.
Nanda NC; Wistran DC; Karlsberg RP; Hack TC; Smith WB; Foley DA; Picard MH; Cotter B
Echocardiography; 2002 Jan; 19(1):27-36. PubMed ID: 11884252
[TBL] [Abstract][Full Text] [Related]
16. Benefit of echocontrast-enhanced transcranial arterial color-coded duplex ultrasound.
Droste DW; Boehm T; Ritter MA; Dittrich R; Ringelstein EB
Cerebrovasc Dis; 2005; 20(5):332-6. PubMed ID: 16131802
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent.
Broillet A; Puginier J; Ventrone R; Schneider M
Invest Radiol; 1998 Apr; 33(4):209-15. PubMed ID: 9556745
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of echocontrast agents in neurosonology.
Droste DW; Metz RJ
Neurol Res; 2004 Oct; 26(7):754-9. PubMed ID: 15494117
[TBL] [Abstract][Full Text] [Related]
19. Transcranial harmonic power duplex sonography for the evaluation of cerebral arteries.
Seidel G; Christoph A; Algermissen C; Katzer T; Claasen L; Vidal-Langwasser M
J Neuroimaging; 2000 Oct; 10(4):216-20. PubMed ID: 11147400
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of SonoVue-enhanced color duplex sonography of vascular structures.
Spinazzi A; Llull JB
Acad Radiol; 2002 May; 9 Suppl 1():S246-50. PubMed ID: 12019881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
